Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2004; 25(04): 22-28
DOI: 10.1055/s-0041-1733092
Review Article

Recent Trends in Cancer Pain Management

Seema Mishra
Department of Anaesthesiology IRCH, AIIMS, India
,
Sushma Bhatnagar
Department of Anaesthesiology IRCH, AIIMS, India
,
Amit Kumar Singhal
Department of Anaesthesiology IRCH, AIIMS, India
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints


Publication History

Article published online:
28 March 2022

© 2004. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Dermot R.Fitzgibbon. Cancer Pain: Management. In: John D Loeser, Stephen H Butler, C Richard Chapmen and Dennis C Turk (ed). Bonica’s Management of Pain (3rd ed). Philadelphia: Lippincott Williams & Wilkins 2001;659-703.
  • 2 Zimmerman l, Story KT, Gaston-Johansson F, Rowles JR. psychological variables and cancer pain. Cancer Nurs 1996;19:44-53.
  • 3 Foley KM. Pain syndromes in patients with cancer. Med Clin North Am 1987;71:169-184.
  • 4 Rich Payne and Gilbert RG et al. Management of pain. In: Derek Doyle, Geoffrey Hanks, Nathan Cherny and Kennanth Calman (eds). Oxford Text Book of Palliative medicine (3rd ed) New York: Oxford University Press 2003:288-458.
  • 5 Jacox AK, Carr DD, Payne R et al. Management of cancer pain: clinical practice guidelines No. 9. Rockville, MD: Agency for healthcare policy and research, US department of Health and Human Services, Public Health Service 1994: AHCPR Publication No. 94-0592.
  • 6 World Health organization: Cancer pain relief. 2nd edition. Geneva. Switzerland: World Health Organization, 1996.
  • 7 Zenz M, Zenz T, Tryba M et al. Severe under treatment of cancer pain: a 3 year survey of the German citation. J Pain Symptom Manage 1995;10:187-191
  • 8 Von Roenn JH, Cleeland CS, Gonin R et al. Physician attitude and practice in cancer pain management: a survey from the Easteran Cooperative Oncology Group and Internal Medicine 1993;119:121-126.
  • 9 Miguel R. Interventional treatment of cancer pain: the fourth step in the world health organization analgesic ladder? Cancer control 2000;7:149-156.
  • 10 Galer BS, Coyle N, Pasternak GW et al. Individual variability in response to different opioids: report of 5 cases. Pain 1992;49(1):87-91.
  • 11 Mercandante S, Portenoy RK: Opioid poorly – responsive cancer pain. Part 3. Clinical strategies to improve opioid responsives. J. of Pain Symptom Manage 2001;21(4):338-354.
  • 12 Payne R, Coluzzi P, Hart et al: Long term safety of oral Tran’s mucosal fentanyl citrate for breakthrough cancer pain. J Pain symptom Manage 2001;22(1):575-583.
  • 13 Lynn C. Hartmann, Katherine M, et al. Management of cancer pain, safe adequate analgesia to improve quality of life. Postgraduate Medicine 2000;107:267-276.
  • 14 Porter J, Jick H. Addiction rare in patients treated with narcotics (letter). N Eng J Med 1980;302(2):123.
  • 15 Caraceni A, Zecca E, Martini C et al. Differences in gabapentine efficacy for cancer pain more apparent than rare? J. Pain Symptom Manage 2001;21(2):93-94.
  • 16 Small EJ, Smith MR, and Seaman JJ et al: Combined analysis of two multicenter, randomized placebo controlled studies of palmidronate disodium for the palliation of bone pain in men with metastatic prostate cancer. J Clin Oncology 2003;21(23):4277-4284.
  • 17 Neville-Webbe H, Coleman RE. Use of zoledronic acid in the management of metastatic bone disease in hypercalcemia. Palliat Med 2003;17(6):539-553.
  • 18 Berenson JR, Rosen LS, Howell a et al. Zolendronic acid reduces skeletal –related events in patients with osteolytic metastasis. Cancer 2001;91(7)1191-1200.
  • 19 Staats PS, Yearwood T, and Charapata SG, et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial JAMA 2004;291:291:63-70.
  • 20 Smith TJ, Staats PS, Deer T et al: Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug related toxicity and survival. J clinical Oncology 2002;20(19)4040-4049.
  • 21 Lordon SP. Interventional approach to cancer pain. Curr Pain Headache Rep. 2002;6:202-206.
  • 22 Geurts JW et al. Efficacy of radiofrequency procedures for treatment of spinal pain: a systematic review of randomized clinical trials. Regional Anaesthesia and Pain Med 2001;26:394-400.
  • 23 Gailbert P, Deramond H, Rosat P, LeGars D. A method for certain spinal hemangiomas; percutaneous vertebroplasty with acrylic cement. Neuroichirurgie 1987;33:166-168.
  • 24 Fourney DR, Schomer DF, Nader R et al. Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. Journal of neurosurgery 2003;98(1):21-30.